Analysis of DNA relaxation and cleavage activities of recombinant Mycobacterium tuberculosis DNA topoisomerase i from a new expression and purification protocol

Thirunavukkarasu Annamalai, Neil Dani, Bokun Cheng, Yuk Ching Tse-Dinh

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Abstract. Background. Mycobacterium tuberculosis DNA topoisomerase I is an attractive target for discovery of novel TB drugs that act by enhancing the accumulation of the topoisomerase-DNA cleavage product. It shares a common transesterification domain with other type IA DNA topoisomerases. There is, however, no homology between the C-terminal DNA binding domains of Escherichia coli and M. tuberculosis DNA topoisomerase I proteins. Results. A new protocol for expression and purification of recombinant M. tuberculosis DNA topoisomerase I (MtTOP) has been developed to produce enzyme of much higher specific activity than previously characterized recombinant enzyme. MtTOP was found to be less efficient than E. coli DNA topoisomerase I (EcTOP) in removal of remaining negative supercoils from partially relaxed DNA. DNA cleavage by MtTOP was characterized for the first time. Comparison of DNA cleavage site selectivity with EcTOP showed differences in cleavage site preferences, but the preferred sites of both enzymes have a C nucleotide in the -4 position. Conclusion. Recombinant M. tuberculosis DNA topoisomerase I can be expressed as a soluble protein and purified in high yield from E. coli host with a new protocol. Analysis of DNA cleavage with M. tuberculosis DNA substrate showed that the preferred DNA cleavage sites have a C nucleotide in the -4 position.

Original languageEnglish (US)
Article number18
JournalBMC Biochemistry
Volume10
Issue number1
DOIs
StatePublished - Aug 10 2009
Externally publishedYes

Fingerprint

Type I DNA Topoisomerase
DNA Cleavage
Mycobacterium tuberculosis
Purification
DNA
Escherichia coli
Enzymes
DNA Topoisomerases
Nucleotides
Transesterification
Proteins

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology

Cite this

Analysis of DNA relaxation and cleavage activities of recombinant Mycobacterium tuberculosis DNA topoisomerase i from a new expression and purification protocol. / Annamalai, Thirunavukkarasu; Dani, Neil; Cheng, Bokun; Tse-Dinh, Yuk Ching.

In: BMC Biochemistry, Vol. 10, No. 1, 18, 10.08.2009.

Research output: Contribution to journalArticle

@article{a01c651184bc405185a90f146570d086,
title = "Analysis of DNA relaxation and cleavage activities of recombinant Mycobacterium tuberculosis DNA topoisomerase i from a new expression and purification protocol",
abstract = "Abstract. Background. Mycobacterium tuberculosis DNA topoisomerase I is an attractive target for discovery of novel TB drugs that act by enhancing the accumulation of the topoisomerase-DNA cleavage product. It shares a common transesterification domain with other type IA DNA topoisomerases. There is, however, no homology between the C-terminal DNA binding domains of Escherichia coli and M. tuberculosis DNA topoisomerase I proteins. Results. A new protocol for expression and purification of recombinant M. tuberculosis DNA topoisomerase I (MtTOP) has been developed to produce enzyme of much higher specific activity than previously characterized recombinant enzyme. MtTOP was found to be less efficient than E. coli DNA topoisomerase I (EcTOP) in removal of remaining negative supercoils from partially relaxed DNA. DNA cleavage by MtTOP was characterized for the first time. Comparison of DNA cleavage site selectivity with EcTOP showed differences in cleavage site preferences, but the preferred sites of both enzymes have a C nucleotide in the -4 position. Conclusion. Recombinant M. tuberculosis DNA topoisomerase I can be expressed as a soluble protein and purified in high yield from E. coli host with a new protocol. Analysis of DNA cleavage with M. tuberculosis DNA substrate showed that the preferred DNA cleavage sites have a C nucleotide in the -4 position.",
author = "Thirunavukkarasu Annamalai and Neil Dani and Bokun Cheng and Tse-Dinh, {Yuk Ching}",
year = "2009",
month = "8",
day = "10",
doi = "10.1186/1471-2091-10-18",
language = "English (US)",
volume = "10",
journal = "BMC Biochemistry",
issn = "1471-2091",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Analysis of DNA relaxation and cleavage activities of recombinant Mycobacterium tuberculosis DNA topoisomerase i from a new expression and purification protocol

AU - Annamalai, Thirunavukkarasu

AU - Dani, Neil

AU - Cheng, Bokun

AU - Tse-Dinh, Yuk Ching

PY - 2009/8/10

Y1 - 2009/8/10

N2 - Abstract. Background. Mycobacterium tuberculosis DNA topoisomerase I is an attractive target for discovery of novel TB drugs that act by enhancing the accumulation of the topoisomerase-DNA cleavage product. It shares a common transesterification domain with other type IA DNA topoisomerases. There is, however, no homology between the C-terminal DNA binding domains of Escherichia coli and M. tuberculosis DNA topoisomerase I proteins. Results. A new protocol for expression and purification of recombinant M. tuberculosis DNA topoisomerase I (MtTOP) has been developed to produce enzyme of much higher specific activity than previously characterized recombinant enzyme. MtTOP was found to be less efficient than E. coli DNA topoisomerase I (EcTOP) in removal of remaining negative supercoils from partially relaxed DNA. DNA cleavage by MtTOP was characterized for the first time. Comparison of DNA cleavage site selectivity with EcTOP showed differences in cleavage site preferences, but the preferred sites of both enzymes have a C nucleotide in the -4 position. Conclusion. Recombinant M. tuberculosis DNA topoisomerase I can be expressed as a soluble protein and purified in high yield from E. coli host with a new protocol. Analysis of DNA cleavage with M. tuberculosis DNA substrate showed that the preferred DNA cleavage sites have a C nucleotide in the -4 position.

AB - Abstract. Background. Mycobacterium tuberculosis DNA topoisomerase I is an attractive target for discovery of novel TB drugs that act by enhancing the accumulation of the topoisomerase-DNA cleavage product. It shares a common transesterification domain with other type IA DNA topoisomerases. There is, however, no homology between the C-terminal DNA binding domains of Escherichia coli and M. tuberculosis DNA topoisomerase I proteins. Results. A new protocol for expression and purification of recombinant M. tuberculosis DNA topoisomerase I (MtTOP) has been developed to produce enzyme of much higher specific activity than previously characterized recombinant enzyme. MtTOP was found to be less efficient than E. coli DNA topoisomerase I (EcTOP) in removal of remaining negative supercoils from partially relaxed DNA. DNA cleavage by MtTOP was characterized for the first time. Comparison of DNA cleavage site selectivity with EcTOP showed differences in cleavage site preferences, but the preferred sites of both enzymes have a C nucleotide in the -4 position. Conclusion. Recombinant M. tuberculosis DNA topoisomerase I can be expressed as a soluble protein and purified in high yield from E. coli host with a new protocol. Analysis of DNA cleavage with M. tuberculosis DNA substrate showed that the preferred DNA cleavage sites have a C nucleotide in the -4 position.

UR - http://www.scopus.com/inward/record.url?scp=68149119087&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68149119087&partnerID=8YFLogxK

U2 - 10.1186/1471-2091-10-18

DO - 10.1186/1471-2091-10-18

M3 - Article

C2 - 19519900

AN - SCOPUS:68149119087

VL - 10

JO - BMC Biochemistry

JF - BMC Biochemistry

SN - 1471-2091

IS - 1

M1 - 18

ER -